Sumitomo Mitsui Trust Holdings, Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 293,542 shares of ALNY stock, worth $141 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
293,542
Previous 291,476
0.71%
Holding current value
$141 Million
Previous $78.7 Million
21.62%
% of portfolio
0.06%
Previous 0.06%
Shares
31 transactions
Others Institutions Holding ALNY
# of Institutions
763Shares Held
115MCall Options Held
584KPut Options Held
661K-
Capital World Investors Los Angeles, CA16.8MShares$8.08 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$6.4 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.59 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.46 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.28MShares$2.06 Billion0.88% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $59.2B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...